Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-05

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, approving a new generic form of the antidepressant and smokin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (generic) (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)